• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 14, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Chemicals for pharmaceuticals could be made cheaper and greener by new catalysts

Bioengineer by Bioengineer
October 1, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: University of Warwick

High value chemicals used to make pharmaceuticals could be made much cheaper and quicker thanks to a series of new catalysts made by scientists at the University of Warwick in collaboration with GoldenKeys High-Tech Co., Ltd. in China.

The process of making high-value chemicals for uses such as the pharmaceutical or electronics chemical industry requires many years of work and a very high financial investment, with a large amount of side products going to waste.

However, in research published in the ACS journal Organic Letters, the paper: ‘Probing the Effects of Heterocyclic Functionality in [(Benzene) Ru (TsDPENR)CI] Catalysts for Asymmetric Transfer Hydrogenation’, shows how scientists are able to tailor conditions in the catalyst to make the molecule required.

The research project between the University of Warwick and the GoldenKeys High-Tech Materials Co., Ltd., a Speciality Material Company led by Dr. Yingjian Xu FRSC in China, has resulted in the development of a series of new catalysts for the asymmetric synthesis of alcohols which could be used for high value chemicals such as pharmaceuticals and electronics chemicals, potentially making it faster, cheaper and more environmentally sustainable as less chemicals are required under the catalytic conditions.

Researchers were able to make the catalyst by making the molecules’ ligands – which act as building blocks, bind to the metal ruthenium.
This means that scientists can pick and choose which molecules to bind together to make a catalyst and in turn make the chemical required in a much faster and more sustainable way.

In some cases the ligands are ‘bidentate’ – meaning they form two bonds to the metal, and in other cases they are ‘tridentate’ – forming three bonds to the metal. Knowing how each ligand will bind also helps the identification of the optimal active form and the conditions required for the target application.

Professor Martin Wills from the Department of Chemistry at the University of Warwick comments:

“The ability to make high-value chemicals through our new series of catalysts using ruthenium metal means that they can be made much more sustainably.

Dr. Yingjian Xu of GoldenKeys High-Tech Materials Co., Ltd. adds:

“If this method is used in the pharmaceutical and electronics chemical industries for example then products and intermediates can potentially be made more cheaply and quickly with higher purity for consumers and reduce waste as less material is needed to make the catalyst, unlike traditional stoichiometric methods.”

###

NOTES TO EDITORS

Image of researchers available at: https://warwick.ac.uk/services/communications/medialibrary/images/september2019/jbr_mw_yx_2018.jpg

Credit: University of Warwick. Caption: Researchers from left to right: Jonathan Barrios-Rivera, Martin Wills, Yingjian Xu

Paper available to view at: https://pubs.acs.org/toc/orlef7/21/18?ai=6562

For further information please contact:

Alice Scott

Media Relations Manager – Science

University of Warwick

Tel: +44 (0) 2476 574 255 or +44 (0) 7920 531 221

E-mail: [email protected]

Media Contact
Alice Scott
[email protected]

Original Source

https://warwick.ac.uk/newsandevents/pressreleases/high_value_chemicals

Related Journal Article

http://dx.doi.org/10.1021/acs.orglett.9b02339

Tags: BiochemistryBiomedical/Environmental/Chemical EngineeringChemistry/Physics/Materials SciencesIndustrial Engineering/ChemistryPharmaceutical ChemistryPharmaceutical SciencePharmaceutical SciencesPharmaceutical/Combinatorial Chemistry
Share12Tweet8Share2ShareShareShare2

Related Posts

Comprehensive Review Explores MDMA’s Role in PTSD Treatment and Emerging Psychiatric Applications

October 14, 2025

Predicting AML Chemosensitivity with ARTN and CCL23

October 14, 2025

Immunity to Measles Reaches 90% in British Columbia’s Lower Mainland

October 14, 2025

2024 NASEM Long COVID Definition: Research Foundation

October 14, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1237 shares
    Share 494 Tweet 309
  • New Study Reveals the Science Behind Exercise and Weight Loss

    104 shares
    Share 42 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    101 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    91 shares
    Share 36 Tweet 23

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Psychedelics Unveil Innovative Therapeutic Approaches for Stress-Related Psychiatric Disorders

New Brain Cell Discoveries Revolutionize Understanding of Psychiatric Disorders

Comprehensive Review Explores MDMA’s Role in PTSD Treatment and Emerging Psychiatric Applications

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 65 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.